Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 6.53x is 47% above its estimated 1-year average of 4.45x, around the middle of its estimated 1-year range (0.69x–12.14x).
As of 2026-10-06T17:03:54.346Z.
Calculation as of: 2026-10-06T17:03:54.346Z.
Quote observation: 2026-10-06T17:00:48.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e871ea8067f28394f736e732b3966b53b535a0e4ae5ed833c49956b30cd07697
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
6.53x
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.77x
median of 205 covered companies
CURRENT VS SECTOR MEDIAN
-58.59%
vs the sector median at left
Market Cap
$243.66M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.31M
EV/EBITDA Ratio
N/A
TTM Avg
28.93x
3Y Avg
31.09x
5Y Avg
27.66x
Market Cap
$240.38M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$241.78M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$240.34M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Q32 Bio Inc. (QTTB) | $244.06M | 6.53x | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.66M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.31M | N/A | 28.93x | 31.09x | 27.66x |
| Galectin Therapeutics Inc. (GALT)vs › | $240.38M | N/A | N/A | N/A | N/A |
| Quantum-Si incorporated (QSI)vs › | $246.31M | N/A | N/A | N/A | N/A |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $241.78M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $240.52M | N/A | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.34M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $237.88M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.27M | N/A | 21.13x | 83.14x | 83.14x |
At 6.5, EV/EBITDA is above its estimated 1-year median — higher than 78% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
0.7
median
3.6
estimated 1-year high
12.1
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 0.78x |
| 2026-10-02 | 0.69x |
| 2026-10-01 | 0.70x |
| 2026-09-30 | 0.71x |
| 2026-09-29 | 1.52x |
| 2026-09-28 | 1.33x |
| 2026-09-25 | 1.03x |
| 2026-09-24 | 1.32x |
| 2026-09-23 | 1.54x |
| 2026-09-22 | 2.19x |
| 2026-09-21 | 2.13x |
| 2026-09-18 | 2.17x |
| 2026-09-17 | 2.38x |
| 2026-09-16 | 2.46x |
| 2026-09-15 | 2.58x |
| 2026-09-14 | 2.41x |
| 2026-09-11 | 2.53x |
| 2026-09-10 | 2.29x |
| 2026-09-09 | 2.56x |
| 2026-09-08 | 2.91x |
| 2026-09-04 | 3.11x |
| 2026-09-03 | 3.63x |
| 2026-09-02 | 4.13x |
| 2026-09-01 | 4.63x |
| 2026-08-31 | 4.96x |
| 2026-08-28 | 5.06x |
| 2026-08-27 | 5.78x |
| 2026-08-26 | 5.80x |
| 2026-08-25 | 5.89x |
| 2026-08-24 | 5.92x |
| 2026-08-21 | 5.67x |
| 2026-08-20 | 5.60x |
| 2026-08-19 | 5.58x |
| 2026-08-18 | 5.23x |
| 2026-08-17 | 5.65x |
| 2026-08-14 | 5.14x |
| 2026-08-13 | 5.28x |
| 2026-08-12 | 5.28x |
| 2026-08-11 | 5.31x |
| 2026-08-10 | 5.47x |
| 2026-08-07 | 5.43x |
| 2026-08-06 | 5.81x |
| 2026-08-05 | 8.97x |
| 2026-08-04 | 8.76x |
| 2026-08-03 | 8.12x |
| 2026-07-31 | 8.45x |
| 2026-07-30 | 8.37x |
| 2026-07-29 | 7.77x |
| 2026-07-28 | 8.47x |
| 2026-07-27 | 8.14x |
| 2026-07-24 | 8.10x |
| 2026-07-23 | 8.25x |
| 2026-07-22 | 8.06x |
| 2026-07-21 | 8.27x |
| 2026-07-20 | 8.03x |
| 2026-07-17 | 8.04x |
| 2026-07-16 | 8.14x |
| 2026-07-15 | 8.46x |
| 2026-07-14 | 10.25x |
| 2026-07-13 | 12.14x |
| 2026-07-10 | 5.55x |
| 2026-07-09 | 6.45x |
| 2026-07-08 | 7.41x |
| 2026-07-07 | 7.11x |
| 2026-07-06 | 6.63x |
| 2026-07-02 | 6.77x |
| 2026-07-01 | 6.45x |
| 2026-06-30 | 6.54x |
| 2026-06-29 | 7.45x |
| 2026-06-26 | 6.82x |
| 2026-06-25 | 6.03x |
| 2026-06-24 | 5.52x |
| 2026-06-23 | 5.99x |
| 2026-06-22 | 6.49x |
| 2026-06-18 | 6.00x |
| 2026-06-17 | 6.65x |
| 2026-06-16 | 6.55x |
| 2026-06-15 | 6.62x |
| 2026-06-12 | 6.48x |
| 2026-06-11 | 6.52x |
| 2026-06-10 | 6.63x |
| 2026-06-09 | 5.99x |
| 2026-06-08 | 6.08x |
| 2026-06-05 | 6.78x |
| 2026-06-04 | 7.36x |
| 2026-06-03 | 6.19x |
| 2026-06-02 | 6.48x |
| 2026-06-01 | 5.84x |
| 2026-05-29 | 5.45x |
| 2026-05-28 | 4.97x |
| 2026-05-27 | 6.62x |
| 2026-05-26 | 2.89x |
| 2026-05-22 | 2.05x |
| 2026-05-21 | 1.86x |
| 2026-05-20 | 1.97x |
| 2026-05-19 | 2.23x |
| 2026-05-18 | 2.02x |
| 2026-05-15 | 2.37x |
| 2026-05-14 | 2.34x |
| 2026-05-13 | 2.14x |
| 2026-05-12 | 2.06x |
| 2026-05-11 | 1.65x |
| 2026-05-08 | 1.77x |
| 2026-05-07 | 1.82x |
| 2026-05-06 | 1.84x |
| 2026-05-05 | 2.02x |
| 2026-05-04 | 1.94x |
| 2026-05-01 | 1.94x |
| 2026-04-30 | 2.37x |
| 2026-04-29 | 2.29x |
| 2026-04-28 | 2.46x |
| 2026-04-27 | 2.27x |
| 2026-04-24 | 2.84x |
| 2026-04-23 | 3.04x |
| 2026-04-22 | 3.17x |
| 2026-04-21 | 3.00x |
| 2026-04-20 | 3.17x |
| 2026-04-17 | 2.56x |
| 2026-04-16 | 2.46x |
| 2026-04-15 | 2.74x |
| 2026-04-14 | 2.58x |
| 2026-04-13 | 2.23x |
| 2026-04-10 | 1.95x |
| 2026-04-09 | 1.85x |
| 2026-04-08 | 2.27x |
| 2026-04-07 | 2.60x |
| 2026-04-06 | 2.40x |
| 2026-04-02 | 2.97x |
| 2026-04-01 | 2.76x |
| 2026-03-31 | 3.00x |
| 2026-03-30 | 2.60x |
| 2026-03-27 | 3.63x |
| 2026-03-26 | 3.55x |
| 2026-03-25 | 3.63x |
| 2026-03-24 | 3.67x |
| 2026-03-23 | 3.26x |
| 2026-03-20 | 3.20x |
| 2026-03-19 | 3.19x |
| 2026-03-18 | 2.53x |
| 2026-03-17 | 2.78x |
| 2026-03-16 | 2.90x |
| 2026-03-13 | 3.30x |
| 2026-03-12 | 3.47x |
| 2026-03-11 | 3.37x |
